Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact
November 14, 2006, 1:00 p.m. – 3:00 p.m. EDT
Taking Clinical Trials and Patient Recruitment Global
SPEAKERS FOR THIS EVENT:
- Jim Kremidas, Global Enrollment Optimization, Eli Lilly Learn More

- Peter DiBiaso, MHA, Director, Worldwide Development Operations, Pfizer Global Research & Development
Learn More
-
Kenneth J. Tomaszewski, PhD, MS,
SVP, Healthcare Research, Harris Interactive
- Gail Adinamis, President, CEO, Clinical Resource Network, Inc.

Archive Options
Audio Only
 Podcast Options
iTunes Podcast SubscribeAll Podcast OptionsListen Now! To all archive in the Podcast

Strategies for Accelerating Patient Recruitment

Pharmaceutical and Biotech companies are under tremendous pressure to cut costs when it comes to clinical trials.  Conducting clinical trials is a complex process that requires coordination of regulatory, marketing and scientific needs – making any delay in the process costly.  Global patient recruitment is a significant and often complicated element of this process.

As the North American patient pool decreases, pharmaceutical and biotech companies are increasingly crossing their borders and pursuing patients from other countries like India and Japan .  While this has resulted in an explosion of new subjects, global patient recruitment is not without its dangers and complications. 

Searching internationally has subjected pharmaceutical and biotech companies to new and varying regulations, cultures, norms and expectations.  In a time when every move made by life science companies is scrutinized, this new trend has left them exposed.

Join this interactive web conference to learn from industry leaders how to optimize the global patient recruitment process. 


Take away points include:

  • International site management

  • Implementing and conducting successful multinational patient recruitment

  • Conducting clinical trials in emerging economies

  • Dealing with home-country and host-country regulations

  • Recruiting special groups, like pediatrics, globally

     

THIS PROGRAM IS INTENDED FOR :

VPs, Directors, Heads & Managers of:

  • Clinical Trials
  • Clinical Development
  • Recruitment Services
  • Clinical Trial Recruitment
  • Study Leaders
  • Outsourcing
  • R&D
  • Clinical Operations

Within the pharmaceutical and biotech industries

 

SPONSORING PARTNERS:
 

Clinical Resource Network, Inc. is a leading national provider of specialized in-home and alternate-site nursing, pharmacy and phlebotomy services for phase I-IV studies conducted in the US and Canada.  These services decrease development time by accelerating patient enrollment, enhancing compliance and reducing dropouts.  CRN supports trials in all therapeutic categories and age groups.  CRN centrally manages an extensive network of over 10,000 traveling nurses and homecare pharmacists and over 5,000 mobile phlebotomists.  Services are available 365 days a year: 

  • Study drug storage, compounding, dispensing, delivery
  • Study drug administration (IV, SQ, oral)
  • Blood draws and processing (safety labs, serial pK draws)
  • Patient assessments and education
  • Study documentation

CRN services are particularly beneficial for long-term studies or studies with frequent visits where patients are unreliable, unable, or unwilling to travel to the investigator’s site for drug administration, blood draws or assessments.   

CRN is a diversity company and has been exceeding expectations for over 12 years. http://www.clinicalresource.net/

 

Harris Interactive, the 12th largest and fastest-growing market research firm in the world, provides custom, global research solutions. Offering a consultative approach that is focused on delivering actionable results and decision support, our 40+ years of healthcare experience has made us a world leader in patient and physician research, and enables us to provide unique insights to help you make better decisions. http://www.harrisinteractive.com/services/clinicaltrials.asp

MEDIA PARTNER:
 

Can Biotech is a web portal and B2B Marketplace profiling therapeutics biotechnology and pharmaceuticals in Canada, the U.S., the U.K., India and other emerging markets. Includes the outsourcing marketplace, jobs, news, events, company profiles, research and business resources, the BioMedical Outsourcing Report, the global venture capital database, strategic reports and more. To learn more visit http://www.canbiotech.com/

ABOUT OUR SPEAKERS:


Jim Kremidas, Global Enrollment Optimization, Eli Lilly and Company 

Since 1999, Jim Kremidas has led the clinical trial patient recruitment and retention efforts at Eli Lilly and Company.  In his current role, he is focused on predicting and accelerating the enrollment rates for all corporate studies. Previously, while in Strategic Sourcing he was responsible for the outsourcing of clinical development projects to strategic suppliers including CRO’s and scientific staffing firms.  Prior to his assignment in clinical development strategic sourcing, Mr. Kremidas led Lilly’s efforts to select and establish relationships with direct to consumer and professional advertising agencies, as well as, implement standardized processes for the development and implementation of marketing materials.  For the first 13 years in his career at Lilly, he held various sales and marketing management positions including global market research, marketing plans and pricing. Prior to that, he was an analytical chemist for the Upjohn Company. He is a graduate of Western Michigan University where he studied chemistry and biology.

Mr. Kremidas is a founder and co-chair of the DIA Subcommittee for Patient Recruitment under the Clinical Research Special Interest Area Committee, serves as an advisor to the committee for the development of Good Recruitment Practices and is a member of the Steering Committee for the newly founded Center for Information and Study on Clinical Research Participation (CISCRP)

Peter A. DiBiaso, MHA, Director, Worldwide Development Operations,

Pfizer Global Research & Development

Peter DiBiaso directs the global clinical trial recruitment services business unit in support of Pfizer’s worldwide development operations division. This strategic role is focused on the organization’s commitment to increase productivity by partnering early with project teams to optimize country placement, investigator site performance, reduce research timelines and execute clinical trial recruitment and retention plans across Pfizer’s drug development portfolio.

Prior to joining Pfizer Peter was a Vice President of Client Development for BBK Healthcare, Inc. where he led the healthcare communications firm’s business relationships on behalf of their pharmaceutical, biotechnology and medical device clients.

Over his 17-year career Peter has also worked in the healthcare technology, policy and disease management industries having served as a founding executive board member of the Disease Management Association of America (DMAA). He is also active in the Drug Information Association (DIA). Peter is a frequent contributor to trade journals and is a featured speaker at international conference and industry association events.

Peter has earned an undergraduate degree in Worksite Health Promotion from East Carolina University and a Master’s degree in Health Services Administration from the George Washington University.


Kenneth J. Tomaszewski, PhD, MS,
SVP, Healthcare Research, Harris Interactive


Dr. Ken Tomaszewski, Senior Vice President, Healthcare Research, Harris Interactive, has an extensive healthcare and policy research background, spanning 12 years in both academic and private sectors.  His areas of expertise also include discrete choice decision modeling, market share, and loyalty analysis, most of which focused on pharmaceutical and medical technology.  At Harris Interactive, Ken oversees several teams focusing on pharmaceutical, medical device, and other market and health services research, including patient and physician recruitment for clinical trials. 

Ken earned his Ph.D. in Health Services Research and Policy from the University of Rochester School of Medicine, where he is also currently an Adjunct Assistant Professor of Health Economics. He earned his M.S. in Public Policy Analysis, also at the University of Rochester.  Since 2001, he has published articles in Neurology (2001), Health Services Research (2001), American Journal of Public Health (2003), and Epilepsy and Behavior (2004). In 2005, Ken presented a CME session at the American Pharmacists Association conference on advancements in online qualitative techniques.

Gail Adinamis, President, CEO, Clinical Resource Network, Inc.

Gail Adinamis is president and CEO of Clinical Resource Network, Inc. (CRN), a diversity company specializing in the provision of in-home nursing and pharmacy services to facilitate clinical trials in North America. 

Ms. Adinamis has over 25 years of comprehensive phase I-IV clinical trials experience including over 12 years of global clinical trials management at Abbott Laboratories and Astellas Pharma US.  She also established the clinical trials divisions for three national homecare companies and served as president of those wholly-owned subsidiaries.

Ms. Adinamis is a member of the Women’s President Organization, the DIA and ACRP. She has been recognized by numerous Who’s Who organizations and has been an invited speaker at several industry conferences.

 
 
Copyright © 2016-2017 Honeycomb Worldwide Inc.